Sintilimab in Combination with Cetuximab and Chemotherapy As First-line Treatment for RAS/BRAF Wild-type Advanced Colorectal Cancer: an Open-label, Non-comparative, Phase 1b/2 Dose Escalation and Expansion Trial
Latest Information Update: 21 Jan 2025
Price :
$35 *
At a glance
- Drugs Sintilimab (Primary) ; Capecitabine; Cetuximab; Fluorouracil; Folinic acid; Irinotecan; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
- 21 Jan 2025 New trial record